News

Manhattan Bridge Capital, Inc. Announces New Quarterly Dividend

Manhattan Bridge Capital, Inc. Announces New Quarterly Dividend

Manhattan Bridge Capital, Inc. Dividend Declaration Announcement

On February 6, 2025, Manhattan Bridge Capital, Inc. (NASDAQ: LOAN) made a significant announcement regarding financial rewards for its shareholders. The company’s board of directors declared a new quarterly dividend of $0.115 per share. This decision marks an important step in the company’s commitment to returning value to its investors.

Details of the Declared Dividend

What Shareholders Can Expect

According to the announcement, the dividend is set to reward all shareholders who are on record by April 8, 2025. This means any investor holding shares of Manhattan Bridge Capital, Inc. as of that date will qualify for the dividend. The actual payments will be distributed on April 15, 2025, providing shareholders with a timely return on their investments.

Impact on Shareholder Value

Declaring a dividend is a noteworthy move for Manhattan Bridge Capital, Inc., indicating the company’s strong financial health and commitment to enhancing shareholder value. Dividends serve as a tangible reward to shareholders, showing that the company is focused on returning profits to those who support it through their investments.

Understanding the Importance of Dividends

Why Dividends Matter

Dividends can play a crucial role in an investor's decision to hold onto shares. They provide regular income and represent a portion of the company’s profitability being distributed among shareholders. Especially in volatile markets, the assurance of dividend payments can draw more investors to a stock, thereby potentially increasing demand.

Historical Context of Dividends at Manhattan Bridge Capital

Historically, Manhattan Bridge Capital, Inc. has maintained a consistent dividend policy, which has proven attractive to both existing and prospective investors. This track record underlines their strategic commitment to providing financial returns through dividends, enhancing investor trust, and stabilizing stock prices.

Future Outlook for Manhattan Bridge Capital, Inc.

Strategic Vision

As Manhattan Bridge Capital, Inc. continues to grow, its robust dividend policies may serve as a significant pillar in its shareholder relations. Market strategies focused on development and investment diversification may further solidify its position in the competitive landscape.

Encouraging Investor Confidence

The recent dividend declaration is not just a gesture of appreciation toward investors; it’s also a strategic move aimed at encouraging further investments. By consistently rewarding shareholders, the company seeks to foster loyalty and confidence in its future endeavors.

Frequently Asked Questions

What is the declared dividend amount for Manhattan Bridge Capital, Inc.?

The declared quarterly dividend amount is $0.115 per share for shareholders of record by April 8, 2025.

When will the dividend be paid out?

The dividend will be paid on April 15, 2025.

Who qualifies for the dividend?

All shareholders of record by April 8, 2025, will qualify for the dividend payment.

How does this dividend declaration affect shareholders?

This declaration is a sign of the company's financial health and commitment to rewarding its investors, providing them with a tangible return on their investment.

What has been the historical dividend policy of Manhattan Bridge Capital, Inc.?

The company has maintained a consistent dividend policy, enhancing investor trust and stabilizing its stock price in the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Infiterra Streamlines Subscription Commerce for MSPs

Updated Category News Views 53

Revolutionizing How MSPs Navigate Subscription Commerce Just when you thought subscription commerce for IT might plateau, Infiterra's stepping up with some slick integration magic. They're rolling out tools that are about to make life a lot easier for Managed Service Providers (MSPs) and IT distributors. Yeah, the technological world spins fast, and these folks want in on...

Continue Reading
Urenco's LEU+ Boosts Future Nuclear Reactor Options

Updated Category News Views 16

Urenco's Leap Forward with LEU+ Well, look who’s shaking up the nuclear scene—Urenco USA, that’s who. They’ve just churned out their first cylinder of low-enriched uranium plus (LEU+) at the National Enrichment Facility in Eunice, New Mexico. This isn’t just any regular Tuesday of uranium talk; it marks a seismic shift for nuclear fuel options in the Western...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 0

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Milwaukee Cylinder Unveils Tech for Longevity in Tough Conditions

Updated Category News Views 54

Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...

Continue Reading
Tips to Pick the Right Primary Care Provider

Updated Category News Views 0

Deciding on Your Healthcare Anchor The quest for the perfect primary care provider isn't just routine; it's a cornerstone to your overall healthcare strategy. When Healthcare Services Expert Sheila A. Berschauer from Moses Lake Community Health lays it all out in HelloNation, she pinpoints selecting a provider as one of the mightiest decisions in your health journey. This...

Continue Reading
Silicone Fluids Market Forecast Hits $10.15B by 2031

Updated Category News Views 84

Unpacking the Prevailing Expansion The global silicone fluids market is marching on a path to significant growth, projected to hit a hefty $10.15 billion by 2031. Now, if you think that's just another number, let's break down why this matters and how the market is changing its stripes. The Rising Tide of Silicone Applications Silicone fluids are not just sliding under the...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 119

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading
Downsizing Tips for Seniors: Start Early, Plan Smart

Updated Category News Views 13

When Change Means Home: Addressing Downsizing Head-On It ain't just about shrinking the square footage when longtime homeowners face the dreaded D-word: downsize. Senior folks around New Philadelphia, Ohio are sitting on an emotional and logistical minefield when it comes to shedding that family home. And who else stepped up to bat but local real estate duo Holly Abel...

Continue Reading
Skanska's Bold CZK 2.2B Prague Venture: What's Brewing?

Updated Category News Views 53

Skanska Rolls the Dice with CZK 2.2 Billion We got Skanska pushing forward with a beefy CZK 2.2 billion investment, translating to about SEK 1 billion, into a new residential phase right in the heart of Prague. It's part of the grand Emil Kolben District project, tasked with blending modern living with low-energy savvy in a city that's slowly shrugging off its industrial...

Continue Reading
ATS Energy Adds Shell Veteran to Fuel Big Ambitions

Updated Category News Views 0

ATS Energy: Charging Ahead with New Leadership There's nothing quite like the spark of new leadership to rev up the energy sector, and ATS Energy—fresh off its Earthshot Prize win—has just thrown in a turbocharged trio. Bringing in seasoned pros with stacks of industrial technology, finance, and infrastructure chops, this isn't your run-of-the-mill board shakeup. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Jones Lang LaSalle's Impressive Growth Potential

Updated Category News Views 167

Analyzing the Growth of Jones Lang LaSalle Jones Lang LaSalle (NYSE: JLL) has delivered remarkable results in the investment landscape over the past five years, showcasing an annualized return that exceeds market expectations by 5.97%. This impressive figure translates into an average annual return of 21.36%, highlighting the strength and reliability of JLL as an...

Continue Reading
Akari Therapeutics to Present at Annual Cancer Meeting

Updated Category News Views 155

Exciting Presentation by Akari Therapeutics at Upcoming Conference Akari Therapeutics, Plc (NASDAQ: AKTX), a pioneering oncology biotechnology firm specializing in antibody drug conjugates (ADCs), has recently achieved a significant milestone. Their abstract has been accepted for oral presentation at a major cancer conference, poised to take place in the near future. This...

Continue Reading
Anchin Expands Leadership with Two New Partners Joining

Updated Category News Views 181

Anchin Welcomes New Partners to Its Growing Team Anchin, a prominent accounting and advisory firm, has exciting news to share about its team's expansion. The firm is proud to announce the addition of two accomplished professionals, Ryan Babiak and Thomas Miranda, to its partnership. As a tax partner and an audit partner, respectively, they bring fresh expertise and...

Continue Reading
StarKist Partners with Kyle Busch Family for Exciting Season

Updated Category News Views 155

StarKist and the Busch Family Kick Off NASCAR 2026 As the exhilarating NASCAR season launches, StarKist Co. is excited to announce its partnership with NASCAR champion Kyle Busch, wellness advocate Samantha Busch, and young racer Brexton Busch. Building upon a successful initial year, this collaboration emphasizes the importance of healthy, ready-to-eat protein options...

Continue Reading
Highlighting Major Tech Developments: Key Releases This Month

Updated Category News Views 177

July in Review: Key Technology Announcements July saw a flurry of significant announcements in the tech world, showcasing innovations and strategies that are set to redefine various industries. This roundup offers insights into the most noteworthy developments that emerged throughout the month. Premarket Highlights Several announcements captured the industry’s...

Continue Reading